Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab in Clinical Islet Transplantation
NCT02727608Phase 2Completed
- Sponsor
- Uppsala University
- Start
- May 2016
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of eculizumab in type 1 diabetes mellitus (T1D), sponsored by Uppsala University. Started May 2016; status: completed.
02
Drugs
eculizumab
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02727608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02727608.